AKT1 and breast cancer: Specifically, several oncogenic miRNAs that are overexpressed in ER+ breast cancer directly target the tumor suppressor PTEN, which dephosphorylates PIP3 and subsequently suppresses PI3K/Akt signaling (Figure 3).